Information
- Type
- Project
- Name
- Sustainable production of biologically active molecules of marine based origin
- Acronym
- BAMMBO
- Description @en
- Innovation is the most important engine of growth and jobs in knowledge-based bio-economies. The scope of BAMMBO (Biologically Active Molecules of Marine Based Origin) is ambitious. This is intentional. BAMMBO will provide innovative solutions to overcome existing bottle-necks associated with culturing marine organisms in order to sustainably produce high yields of value-added products for the pharmaceutical, cosmetic and industrial sectors.
BAMMBO will screen and identify target marine organisms (e.g. bacteria, fungi, sponges, microalgae, macroalgae and yeasts) from diverse global locations for potential as sustainable producers of high-added value molecules (HVAB's). Our project will apply analytical methods for the extraction, purification and enrichment of targeted bioactive compounds. A detailed life cycle analysis of the production pathways developed in the project will be undertaken to fully evaluate the sustainability of production of biologically active products from marine organisms.
BAMMBO will exploit knowledge and technologies developed during the project and effectively manage their transfer to relevant stakeholders in industry and the research community, as well as to policy-makers. We have brought together a multidisciplinary consortium of specialist Research and SME partners representing 8 countries including partners from ICPC countries Russia and Brazil, and from EU member states at Mediterranean, Adriatic and Atlantic coasts. In adhering to the European Strategy for Marine and Maritime Research this three year project will encourage capacity-building, integration and synergies across relevant marine sectors. Innovative technologies developed in the project will be demonstrated with the involvement of industry partners, and the results will be of interest not only to companies directly involved in the marine sector, but to other large scale industry players such as pharmaceutical companies with interest in added-value bioactive compounds.
- Start date
- 2011-3
- End date
- 2014-2